| RS2514000287 |
FKRP
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2514000372 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514000375 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514001984 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514002045 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514002081 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514002471 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514002847 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514003116 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514003614 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514004859 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514006097 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514006203 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514006401 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Inborn genetic diseases |
| RS2514006425 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514006464 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514012560 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514012590 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514012636 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514012697 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514012707 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514012713 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514013177 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514013864 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514014150 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514015864 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514016082 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2514017119 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS2514019854 |
SDHAF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex 2 deficiency, nuclear type 2 |
| RS2514021598 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514022206 |
ATP1A3
|
Health Risk |
Pathogenic |
— |
| RS2514023173 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514023304 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514023319 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514023544 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514023621 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514025233 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514026839 |
SYNE4
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2514027187 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514028081 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514028225 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514028320 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514028404 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514028487 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514028585 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514029012 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514029053 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514029566 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514029570 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514029982 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514030085 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichothiodystrophy 1, photosensitive |
| RS2514030262 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514030892 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514030959 |
ERCC2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2514031946 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514032024 |
SYNE4
|
Health Risk |
Likely pathogenic |
— |
| RS2514032270 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS2514032458 |
ATP1A3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 99, Developmental and epileptic encephalopathy 99 |
| RS2514032524 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 2, Neurodevelopmental delay |
| RS2514032567 |
ATP1A3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2514032584 |
SYNE4
|
Health Risk |
Likely pathogenic |
— |
| RS2514033812 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514033848 |
ERCC2
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514033921 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum |
| RS2514033986 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514034313 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514034822 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514035206 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514037668 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514037904 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514038071 |
SYNE4
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Autosomal recessive nonsyndromic hearing loss 76 |
| RS2514039278 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514039500 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514039620 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514040069 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514040072 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514041357 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514041516 |
SYNE4
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Autosomal recessive nonsyndromic hearing loss 76 |
| RS2514041659 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514041920 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514043086 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514043578 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514043674 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514044862 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514045021 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514045040 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, Cerebrooculofacioskeletal syndrome 2 |
| RS2514045500 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514045659 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514046757 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514046994 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514047010 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS2514047021 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514048150 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514048182 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514048317 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2514048469 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2514048526 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS2514048536 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS2514048836 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514048994 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |